BSEDIPNA PHARMACHEM LIMITEDMediumNeutral
Announced Sat, 24 Oct, 2026 · 16:37 IST

Board changes: one director appointed and two independent directors resign

Multiple Ind Directors ResignedManagement Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.0%Reaction day
₹3.89
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-0.4% vs market
Pharmaceuticals peers, median of 174sector+1.2%-1.2% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.0+0.4-0.4+1.2-1.2
Next day
-2.3+2.1-4.4+3.1-5.4
2d
-4.1pendingpending+4.8-8.9
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

On 10 August 2026, Dipna Pharmachem appointed Nirav Madhusudan Soni as an additional non-executive, non-independent director. Independent directors Jitendra Parmar and Manish Bachani resigned the same day for personal reasons. The Audit, Nomination and Remuneration, and Stakeholders Relationship Committees were reconstituted, with Soni chairing all three.

Likely market impact

Board turnover and committee changes may bring short-term governance uncertainty, but no change to company finances or operations was reported.